Delivery Order SPE2DB20D3103-SPE2DB23FP7B8

Award Date 9/13/23
Potential Completion Date 9/14/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,937.25 delivery order contract is for the supply of 4563074296 - Hydralazine 20 mg/ml vial. The contract has a firm fixed price and an ultimate completion date of December 13, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $1,988.04 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4565236698 - Hydralazine 20 mg/ml vial, with a completion date of July 25, 2024. The award is not designated as a set-aside contract. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,398.12, is for the supply of 4566821134 Hydralazine 20 mg/ml vials. It is a firm fixed-price, delivery order contract with a completion date of January 3, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This contract award is for the delivery of hydralazine 20 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $45,324.24 and is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a $1,398.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYDRALAZINE 20 MG/ML VIALML, a medical product, with a performance period through March 11, 2025. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,472.10 firm fixed price delivery order is for the supply of hydromorphone 1 mg/ml carpujctml, a pain management medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of hydromorphone 1 mg/ml vials, a specialty pain management medication. The contract has a firm fixed price of $5,113.52 and a completion date of April 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,177.28 firm-fixed-price contract has a completion date of January 21, 2025 and covers the provision of a range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,030.84 contract has a performance period ending on May 28, 2024. The order is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,023.20 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that allows AmerisourceBergen to deliver a comprehensive range of pharmaceuticals and medical supplies to military treatment programs and facilities...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP7B8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydralazine 20 mg/ml vials. The $1,126.20 firm fixed-price contract has a completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not include any set-aside designation, indicating open competition. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:23 AM